Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
äŒæ¥ã³ãŒãIART
äŒç€ŸåIntegra Lifesciences Holdings Corp
äžå Žæ¥Aug 16, 1995
æé«çµå¶è²¬ä»»è
ãCEOãPoul (Mojdeh)
åŸæ¥å¡æ°4396
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Aug 16
æ¬ç€Ÿæåšå°1100 Campus Road
éœåžPRINCETON
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·08540
é»è©±çªå·16092750500
ãŠã§ããµã€ãhttps://www.integralife.com/
äŒæ¥ã³ãŒãIART
äžå Žæ¥Aug 16, 1995
æé«çµå¶è²¬ä»»è
ãCEOãPoul (Mojdeh)